Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
DOI:
https://doi.org/10.12775/JEHS.2023.19.01.007Keywords
Selective Serotonin Reuptake Inhibitors, Post-SSRI sexual dysfunction, Sexual dysfunctionAbstract
Introduction: Selective serotonin reuptake inhibitors (SSRIs) are one of the most commonly used drugs. One of the most common side effects are those related to sexual function. We can divide them into sexual dysfunction occurring during the use of SRRIs and those occurring and persisting after discontinuation of SSRIs.
Purpose: To review available PubMed data on SSRI-related sexual dysfunction, epidemiology, symptoms and treatment.
Current state of knowledge: SSRIs are first-line drugs for depression and other mental disorders. Their use can cause sexual dysfunction. SSRI-induced sexual disorders are more common but easier to treat. Post-SSRI sexual dysfunction is less common and harder to treat. There are several hypotheses regarding its pathomechanism, such as epigenetic changes, serotonin neurotoxicity, endocrine disruption, and downregulation of serotonin receptors.
Conclusions: Sexual dysfunction after SSRIs left without treatment increases the chances of self-discontinuation of drugs by patients and contributes to significant suffering. In the case of SSRIs induced sexual dysfunction, there are several possible interventions that can effectively eliminate sexual dysfunction and restore the patient's comfort. There are no effective treatments for post-SSRI sexual dysfunction syndrome. In addition, the diagnosis of PSSD is difficult as there are no specific diagnostic criteria. More research is needed to determine how to diagnose and treat patients who develop PSSD.
References
Brody DJ, Gu Q. Antidepressant use among adults: United States, 2015–2018. NCHS Data Brief, no 377. Hyattsville, MD: National Center for Health Statistics. 2020.
Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
Atmaca M. Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives. Neuropsychiatr Dis Treat. 2020 Apr 20;16:1043-1050. doi: 10.2147/NDT.S185757. PMID: 32368066; PMCID: PMC7182464.
Hutters CL, Giraldi A. [Sexual side effects from treatment with SSRI]. Ugeskr Laeger. 2022 Apr 4;184(14):V11210824. Danish. PMID: 35410653.
Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from:
Healy D. Post-SSRI sexual dysfunction & other enduring sexual dysfunctions. Epidemiol Psychiatr Sci. 2019 Sep 23;29:e55. doi: 10.1017/S2045796019000519. PMID: 31543091; PMCID: PMC8061302.
Rothmore J. Antidepressant-induced sexual dysfunction. Med J Aust. 2020 Apr;212(7):329-334. doi: 10.5694/mja2.50522. Epub 2020 Mar 15. PMID: 32172535.
Baldwin DS, Manson C, Nowak M. Impact of Antidepressant Drugs on Sexual Function and Satisfaction. CNS Drugs. 2015 Nov;29(11):905-13. doi: 10.1007/s40263-015-0294-3. PMID: 26519341.
Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999;60 Suppl 4:4-11; discussion 12-3. PMID: 10086478.
Xue W, Wang P, Li B, Li Y, Xu X, Yang F, Yao X, Chen YZ, Xu F, Zhu F. Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study. Phys Chem Chem Phys. 2016 Jan 28;18(4):3260-71. doi: 10.1039/c5cp05771j. PMID: 26745505.
Preskorn SH. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet. 1997;32 Suppl 1:1-21. doi: 10.2165/00003088-199700321-00003. PMID: 9068931.
David DJ, Gourion D. Antidépresseurs et tolérance : déterminants et prise en charge des principaux effets indésirables [Antidepressant and tolerance: Determinants and management of major side effects]. Encephale. 2016 Dec;42(6):553-561. French. doi: 10.1016/j.encep.2016.05.006. Epub 2016 Jul 14. PMID: 27423475.
Hu XH, Bull SA, Hunkeler EM, Ming E, Lee JY, Fireman B, Markson LE. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry. 2004 Jul;65(7):959-65. doi: 10.4088/jcp.v65n0712. PMID: 15291685.
Rosenberg KP, Bleiberg KL, Koscis J, Gross C. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther. 2003 Jul-Aug;29(4):289-96. doi: 10.1080/00926230390195524. PMID: 14504017.
Keks NA, Hope J, Culhane C. Management of antidepressant-induced sexual dysfunction. Australas Psychiatry. 2014 Dec;22(6):525-8. doi: 10.1177/1039856214556323. Epub 2014 Oct 21. PMID: 25335956.
Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother. 2002 Oct;36(10):1577-89. doi: 10.1345/aph.1A195. PMID: 12243609.
Safarinejad MR. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. J Psychopharmacol. 2011 Mar;25(3):370-8. doi: 10.1177/0269881109351966. Epub 2010 Jan 15. PMID: 20080928.
Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf. 2014 Jan;37(1):19-31. doi: 10.1007/s40264-013-0129-4. PMID: 24338044.
Lorenz T, Rullo J, Faubion S. Antidepressant-Induced Female Sexual Dysfunction. Mayo Clin Proc. 2016 Sep;91(9):1280-6. doi: 10.1016/j.mayocp.2016.04.033. PMID: 27594188; PMCID: PMC6711470.
Lorenz TA, Meston CM. Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trial. Depress Anxiety. 2014 Mar;31(3):188-95. doi: 10.1002/da.22208. PMID: 24754044; PMCID: PMC4039497.
Clayton AH, El Haddad S, Iluonakhamhe JP, Ponce Martinez C, Schuck AE. Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opin Drug Saf. 2014 Oct;13(10):1361-74. doi: 10.1517/14740338.2014.951324. Epub 2014 Aug 22. PMID: 25148932.
Hirsch M, Birnbaum RJ. Sexual dysfunction caused by selective serotonin reuptake inhibitors (SSRIs): management [website]. UpToDate 2019, 24 Aug.
Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997 Fall;23(3):176-94. doi: 10.1080/00926239708403923. PMID: 9292833.
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009 Jun;29(3):259-66. doi: 10.1097/JCP.0b013e3181a5233f. PMID: 19440080.
Francois, Dimitry & Levin, Ariana & Kutscher, Eric & Asemota, Babatunde. (2017). Antidepressant-Induced Sexual Side Effects: Incidence, Assessment, Clinical Implications, and Management. Psychiatric Annals. 47. 154-160. 10.3928/00485713-20170201-01.
Rappek NAM, Sidi H, Kumar J, Kamarazaman S, Das S, Masiran R, Baharuddin N, Hatta MH. Serotonin Selective Reuptake Inhibitors (SSRIs) and Female Sexual Dysfunction (FSD): Hypothesis on its Association and Options of Treatment. Curr Drug Targets. 2018;19(12):1352-1358. doi: 10.2174/1389450117666161227142947. PMID: 28025939.
Moore BE, Rothschild AJ. Treatment of antidepressant-induced sexual dysfunction. Hosp Pract (1995). 1999 Jan 15;34(1):89-91, 95-6. doi: 10.3810/hp.1999.01.127. PMID: 9931578.
Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry. 1995 Oct;152(10):1514-6. doi: 10.1176/ajp.152.10.1514. PMID: 7573593.
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychother Psychosom. 2016;85(5):270-88. doi: 10.1159/000447034. Epub 2016 Aug 11. PMID: 27508501.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawa TA. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528. doi: 10.1002/14651858.CD006528.pub2. PMID: 22161405; PMCID: PMC4158430.
Pereira VM, Arias-Carrión O, Machado S, Nardi AE, Silva AC. Bupropion in the depression-related sexual dysfunction: a systematic review. CNS Neurol Disord Drug Targets. 2014;13(6):1079-88. doi: 10.2174/1871527313666140612112630. PMID: 24923342.
Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2013 May 31;(5):CD003382. doi: 10.1002/14651858.CD003382.pub3. PMID: 23728643.
Reisman Y. Sexual Consequences of Post-SSRI Syndrome. Sex Med Rev. 2017 Oct;5(4):429-433. doi: 10.1016/j.sxmr.2017.05.002. Epub 2017 Jun 20. PMID: 28642048.
Ben-Sheetrit J, Aizenberg D, Csoka AB, Weizman A, Hermesh H. Post-SSRI Sexual Dysfunction: Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Response Relationship. J Clin Psychopharmacol. 2015 Jun;35(3):273-8. doi: 10.1097/JCP.0000000000000300. PMID: 25815755.
Hogan C, Le Noury J, Healy D, Mangin D. One hundred and twenty cases of enduring sexual dysfunction following treatment. Int J Risk Saf Med. 2014;26(2):109-16. doi: 10.3233/JRS-140617. PMID: 24902508.
Bala A, Nguyen HMT, Hellstrom WJG. Post-SSRI Sexual Dysfunction: A Literature Review. Sex Med Rev. 2018 Jan;6(1):29-34. doi: 10.1016/j.sxmr.2017.07.002. Epub 2017 Aug 1. PMID: 28778697.
Csoka AB, Bahrick A, Mehtonen OP. Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J Sex Med. 2008 Jan;5(1):227-33. doi: 10.1111/j.1743-6109.2007.00630.x. Erratum in: J Sex Med. 2008 Dec;5(12):2977.. Csoka, A [corrected to Csoka, AB]. PMID: 18173768.
Bahrick, A. S. (2006). Post SSRI sexual dysfunction. American Society for the Advancement of Pharmacotherapy Tablet, 7(3), 2-3.
Healy D, Le Noury J, Mangin D. Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. Int J Risk Saf Med. 2018;29(3-4):125-134. doi: 10.3233/JRS-180744. PMID: 29733030; PMCID: PMC6004900.
Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses. 2009 Nov;73(5):770-80. doi: 10.1016/j.mehy.2008.10.039. Epub 2009 Jun 5. PMID: 19501473.
Popova NK, Amstislavskaya TG. Involvement of the 5-HT(1A) and 5-HT(1B) serotonergic receptor subtypes in sexual arousal in male mice. Psychoneuroendocrinology. 2002 Jul;27(5):609-18. doi: 10.1016/s0306-4530(01)00097-x. PMID: 11965359.
Keltner NL, McAfee KM, Taylor CL. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care. 2002 Jul-Sep;38(3):111-6. PMID: 12385082.
Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999 Feb;19(1):67-85. doi: 10.1097/00004714-199902000-00013. PMID: 9934946.
de Jong TR, Veening JG, Olivier B, Waldinger MD. Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. J Sex Med. 2007 Jan;4(1):14-28. doi: 10.1111/j.1743-6109.2006.00394.x. PMID: 17233773.
Damsa C, Bumb A, Bianchi-Demicheli F, Vidailhet P, Sterck R, Andreoli A, Beyenburg S. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry. 2004 Aug;65(8):1064-8. doi: 10.4088/jcp.v65n0806. PMID: 15323590.
Van der Ploeg LH, Martin WJ, Howard AD, Nargund RP, Austin CP, Guan X, Drisko J, Cashen D, Sebhat I, Patchett AA, Figueroa DJ, DiLella AG, Connolly BM, Weinberg DH, Tan CP, Palyha OC, Pong SS, MacNeil T, Rosenblum C, Vongs A, Tang R, Yu H, Sailer AW, Fong TM, Huang C, Tota MR, Chang RS, Stearns R, Tamvakopoulos C, Christ G, Drazen DL, Spar BD, Nelson RJ, MacIntyre DE. A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11381-6. doi: 10.1073/pnas.172378699. Epub 2002 Aug 9. PMID: 12172010; PMCID: PMC123265.
Montejo AL, Llorca G, Izquierdo JA, Carrasco JL, Daniel E, Pérez-Sola V, Vicens E, Bousoño M, Sánchez-Iglesias S, Franco M, Cabezudo A, Rubio V, Ortega MA, Puigdellivol M, Domenech JR, Allué B, Sáez C, Mezquita B, Gálvez I, Pacheco L, de Miguel E. Disfunción sexual con antidepresivos. Efecto del cambio a amineptino en pacientes con disfunción sexual secundaria a ISRS [Sexual dysfunction with antidepressive agents. Effect of the change to amineptine in patients with sexual dysfunction secondary to SSRI]. Actas Esp Psiquiatr. 1999 Jan-Feb;27(1):23-34. Spanish. PMID: 10380144.
Waldinger MD, van Coevorden RS, Schweitzer DH, Georgiadis J. Penile anesthesia in Post SSRI Sexual Dysfunction (PSSD) responds to low-power laser irradiation: a case study and hypothesis about the role of transient receptor potential (TRP) ion channels. Eur J Pharmacol. 2015 Apr 15;753:263-8. doi: 10.1016/j.ejphar.2014.11.031. Epub 2014 Dec 4. PMID: 25483212.
Janus M, Szulc A. Seksuologiczne narzędzia diagnostyczne w Polsce i na świecie. Journal of Sexual and Mental Health. Tom 13, Nr 1 (2015)
Sukoff Rizzo SJ, Pulicicchio C, Malberg JE, Andree TH, Stack GP, Hughes ZA, Schechter LE, Rosenzweig-Lipson S. 5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats. Int J Neuropsychopharmacol. 2009 Sep;12(8):1045-53. doi: 10.1017/S1461145709000406. Epub 2009 May 13. PMID: 19435548.
Peleg LC, Rabinovitch D, Lavie Y, Rabbie DM, Horowitz I, Fruchter E, Gruenwald I. Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors. Sex Med Rev. 2022 Jan;10(1):91-98. doi: 10.1016/j.sxmr.2021.07.001. Epub 2021 Oct 7. PMID: 34627736.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Eliasz Panek, Damian Jasłowski, Mateusz Rzeszutko, Przemysław Raczkiewicz, Dominika Panasiuk, Mateusz Skrętowicz, Patrycja Szponarowicz, Bartosz Snopkowski, Tomasz Korzec, Jakub Sosnowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 2753
Number of citations: 0
